Showing results (31-40 of 295) with videos related to
Sort By:
Pageof 30
Journal of the National Comprehensive Cancer Network : JNCCN|August 10, 2022
Regional Variations in Clinical Trial Outcomes in OncologyBrooke E Wilson, Sallie-Anne Pearson, Michael B Barton, et al.American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|April 24, 2026
Value, Access, and High-Quality Medical Oncology Care: Can We Have It All?Ian F Tannock, Ajay Aggarwal, Haydee Verduzco-Aguirre, et al.ANZ Journal of Surgery|August 21, 2012
Appendicectomy at a children's hospital: what has changed over a decade?Brooke E Wilson, Lukas Cheney, Bhavesh Patel, et al.Bladder Cancer (Amsterdam, Netherlands)|July 5, 2016
The Role of Population-Based Observational Research in Bladder CancerAndrew G Robinson, Jason P Izard, Christopher M BoothEuropean Journal of Cancer (Oxford, England : 1990)|June 17, 2014
Disease-free survival as an end-point in the treatment of solid tumours--perspectives from clinical trials and clinical practiceAndrew G Robinson, Christopher M Booth, Elizabeth A EisenhauerJournal of General Internal Medicine|July 12, 2023
The Changing Medical Publishing Industry: Economics, Expansion, and EquityChristopher M Booth, Joseph S Ross, Allan S DetskyJournal of Pain & Palliative Care Pharmacotherapy|August 3, 2005
Rotation to methadone after opioid dose escalation: How should individualization of dosing occur?Camilla Zimmermann, Dori Seccareccia, Christopher M Booth, et al.Journal of Visualized Experiments : Jove|October 3, 2013
Quantitative multispectral analysis following fluorescent tissue transplant for visualization of cell origins, types, and interactionsErika L Spaeth, Christopher M Booth, Frank C MariniCritical Care Medicine|July 20, 2002
Gastrointestinal promotility drugs in the critical care setting: a systematic review of the evidenceChristopher M Booth, Daren K Heyland, William G PatersonEuropean Journal of Cancer (Oxford, England : 1990)|June 30, 2014
Progression-free survival as an end-point in solid tumours--perspectives from clinical trials and clinical practiceAndrew G Robinson, Christopher M Booth, Elizabeth A EisenhauerPageof 30